Skip to main content
S 2022 117th Congress Senate Health Adoption and foster care Cell biology and embryology Child health Emergency medical services and trauma care Genetics Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Health technology, devices, supplies Hospital care Medicaid Medical tests and diagnostic methods State and local government operations

Ending the Diagnostic Odyssey Act of 2021

Introduced: June 10, 2021 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 10, 2021
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)
Jun 10, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Ending the Diagnostic Odyssey Act of 2021

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

What's happening now June 10, 2021

Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4046-4047)

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 2
D
Smith, Tina
Minnesota · Dec 6, 2021
 D
Kelly, Mark
Arizona · Jun 10, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2022: Ending the Diagnostic Odyssey Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2022/
MLA
"S. 2022: Ending the Diagnostic Odyssey Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2022/.
Bluebook (legal)
S. 2022, 117th Cong. (2026), https://openamerica.io/bill/117-S-2022/.
Markdown link
[S. 2022: Ending the Diagnostic Odyssey Act of 2021](https://openamerica.io/bill/117-S-2022/)
Report a problem